Hironori Kanda - Concepedia

Author

Hironori Kanda

Kyowa Kirin (Japan)

Also Known As

Hironori KANDA, Hironori Kanda

Publications

664

Citations

H-Index

Concepts

All Affiliations

Kyowa Kirin (Japan)Showa University University of Tsukuba Tokai University Osaka Hospital

About

Hironori Kanda is an author at Kyowa Kirin (Japan) specializing in medicine, oxidative stress, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	111
2	Biochemistry	3	3	54
3	Metabolism	2	2	36
4	Natural Sciences	1	1	19
5	Chemical Biology	1	1	19

Hironori Kanda

Publications

398

Citations

H-Index

Page 1

	Year	Citations
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study) Masaomi Nangaku, Hironori Kanda, Hirotaka Takama, Kidney International Reports	2020	121
Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia Yasuo Imanishi, Nobuaki Ito, Yumie Rhee, Journal of Bone and Mineral Research	2020	85
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors Hiroshi Wakui, Noboru Yamamoto, Satoru Kitazono, Cancer Chemotherapy and Pharmacology Japanese PatientsOncologyMedicineEg5 InhibitorPharmacotherapy	2014	57
Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, Kidney International Reports	2021	24
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia Takashi Shigematsu, Yotaro Une, Kazuaki Ikejiri, American Journal of Nephrology	2021	23
S-Mercuration of rat sorbitol dehydrogenase by methylmercury causes its aggregation and the release of the zinc ion from the active site Hironori Kanda, Takashi Toyama, Azusa Shinohara-Kanda, Archives of Toxicology Chemical BiologyBiochemistryNatural SciencesMetalloproteinPhysiology	2012	19
Downregulation of arginase II and renal apoptosis by inorganic mercury: overexpression of arginase II reduces its apoptosis Hironori Kanda, Makoto Kikushima, Shino Homma‐Takeda, Archives of Toxicology UrologyBiochemistryMedicineArginase IiRenal Apoptosis	2007	18
Reduction of arginase I activity and manganese levels in the liver during exposure of rats to methylmercury: a possible mechanism Hironori Kanda, Daigo Sumi, Akiko Endo, Archives of Toxicology Manganese LevelsBiochemistryMedicineLiver PhysiologyForensic Toxicology	2008	17
Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients Tadao Akizawa, Yu Sato, Kazuaki Ikejiri, Kidney International Reports	2021	17
Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial Noriyuki Namba, Takuo Kubota, Koji Muroya, Journal of the Endocrine Society	2022	17

Page 1